Study Site 022 — Fort Worth, Texas

Study Site 022 is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Study Site 022 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypoxic-Ischemic Encephalopathy.

Sponsors: ReAlta Life Sciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Worth

Browse all research sites in Texas · View every site in Fort Worth

• Texas Health Harris Methodist Hospital - Fort Worth - Neurology
• Harris Methodist Fort Worth Hospital
• University of North Texas Health Science Center
• Sensation-NOW: University of North Texas/John Peter Smith Hospital
• University of Texas Southwestern Medical Center
• RANGER: University of North Texas/John Peter Smith Hospital
• University of North Texas/Health Sciences Center-Fort Worth
• JP Smith Hospital
• Harris Methodist Southlake Hospital
• Cook's Children Hospital
• TBTC Site 20 UNTHSC (University of North Texas Health Science Center)
• John Peter Smith Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 022?

Study Site 022 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 022 conducted?

Study Site 022 has 1 clinical trials on record, with 1 currently active. Their work covers Hypoxic-Ischemic Encephalopathy.

Is Study Site 022 accredited by Crixeo Clinical Trials?

Study Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.